Novo Nordisk A/S

Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates…

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales…

Anthropic will invest $100 million into an academy for training AI talent, working with companies to integrate artificial…

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

Samuel Boivin | Nurphoto | Getty Images Hello, this is Leonie Kidd coming to you from London. Welcome…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…

Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook